Thursday, December 7, 2023
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO North America > CEO Life > Food > Novo Nordisk claims 80% of US WeGovy users pay less than $25 per month

Novo Nordisk claims 80% of US WeGovy users pay less than $25 per month

in Food
Novo nordisk claims 80% of us wegovy users pay less than $25 per month
Share on LinkedinShare on WhatsApp

While Novo Nordisk’s blockbuster weight loss drug WeGovy has caught repeated flack for its purportedly high price tag, the drug manufacturer revealed new data Tuesday alleging that WeGovy is more affordable to insured Americans than the public may think.

According to Novo Nordisk, approximately 80% of U.S. patients with health insurance only pay $25 per month for their mensual supply of WeGovy.

The company went on to say that more and more employers are opting in to add WeGovy coverage for their employees.
Meanwhile, the list price for a full month of WeGovy sits at $1,350.

Related Posts

Eli lilly’s new weight loss drug hits us pharmacies
Food

Eli Lilly’s new weight loss drug hits US pharmacies

Mounjaro trumps ozempic in weight loss efficacy
Food

Mounjaro trumps Ozempic in weight loss efficacy

Pfizer aims to enter weight loss drugs market
Food

Pfizer aims to enter weight loss drugs market

Pfizer reports q3 losses
Food

Pfizer reports Q3 losses

Taco bell wins ‘taco tuesday’ trademark suit
Food

Taco Bell wins ‘Taco Tuesday’ trademark suit

Johnson & johnson beats earnings expectations
Food

Johnson & Johnson beats earnings expectations

U. S. Cancer centers crippled by lack of drug supply
Food

U.S. cancer centers crippled by lack of drug supply

Chipotle tests robot assembly line
Food

Chipotle tests robot assembly line

Mcdonald’s adds limited-edition sauces to menu
Food

McDonald’s adds limited-edition sauces to menu

Eli lilly sues over diabetes drug knockoffs
Food

Eli Lilly sues over diabetes drug knockoffs

No Result
View All Result

Recent Posts

  • Paris to build ‘urban forest’ amid city infrastructure
  • Google reveals advanced AI model, Gemini
  • TV bundles aim to retake streaming’s crown
  • US mortgage refinance demand surges 14%
  • US consumers purchased one million EVs in 2023

Recent Comments

  • CEO North America, August - September 2023 - CEO North America on Interviews – CEO North America, October – November 2022
  • CEO North America, August - September 2023 - CEO North America on CEO North America, December 2022 – January 2023
  • CEO North America, August - September 2023 - CEO North America on Why Tech Companies Are Moving to Texas and Florida
  • CEO North America, August - September 2023 - CEO North America on CEO North America, February 2023 – March 2023
  • Lab-Grown Milk Has Huge Potential to Disrupt Dairy – Simply Commodities on The dairy industry is in trouble

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Editorials –
stuart.james@ceo-na.com

Advertising –
advertising@ceo-na.com

NEW YORK

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

HOUSTON

1201 Fannin St.
Suite 262
Houston, TX
77002
USA

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Editorials –
stuart.james@ceo-na.com

Advertising –
advertising@ceo-na.com

NEW YORK

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 212 432 5800

HOUSTON

1201 Fannin St.
Suite 262
Houston, TX
77002
USA

CEO North America © 2022 - Sitemap

No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Warning: array_sum() expects parameter 1 to be array, null given in /home/ceonacom/public_html/wp-content/plugins/jnews-social-share/class.jnews-social-background-process.php on line 112